Press

This page contains the most important information about Rehaler and BalancAir, the company behind Rehaler. If you want to know more you can always contact us at support@balancair.com.

BalancAir & Rehaler

  • Founded in 2009. Troels Johansen, the current head of research, founded BalancAir with the aim of developing a new form of gas-free treatment based on gas mixtures to treat a variety of neurological diseases.
  • Spinout from DTU. The first steps in the development of the technology were taken at the Technical University of Denmark.
  • Rehaler Migraine Treatment. BalancAir's first product, Rehaler, utilizes a combination of oxygen and carbon dioxide to effectively stop migraine attacks.
  • Clinical trial. Rehaler has been tested by Aarhus University Hospital In a clinical study with migraine patients with aura.

Download our press kit

The press kit contains additional information about BalancAir, Rehaler, migraine facts, links, images, logos and more.

Introduction to BalancAir and Rehaler

BalancAir is a family-run company established in 2009 by a civil engineer and a Ph.D. Troels Johansen. Today it is headed by CEO Asger Johansen, who is the founder’s brother. The company currently has 12 employees and is located in DTU’s Science Park in Lyngby.

The company focuses on developing and commercializing the CO2 treatment, which can help migraine patients. The treatment is based on the effects of changing the patient’s content of 2 in the blood. The effect of altered 2 content in the blood has been known since the 1950s. Now, BalancAir has had clinical trials documenting and clarifying the method’s effectiveness against what is called “aura migraine”. The experiments were carried out at Aarhus University Hospital in 2016-17.

BalancAir’s first product is called Rehaler and went on sale in the fall of 2018. Rehaler is a system consisting of a disposable inhaler, an oxygen meter and a smartphone treatment app. Rehaler is a system designed to slow down or reduce an on-going migraine attack.

BalancAir is today owned by the family behind the company as well as a number of external investors. The company has raised DKK 19 million so far. Its first product, Rehaler, was launched in Denmark, Sweden and Germany in the fall of 2018.

Migraine is a serious disorder that has major societal consequences. Ca. half a million Danes suffer from migraines. Five per cent. of all visits to the doctor and 14 per cent. of all sick days is considered to be migraine-related, shows data from the Danish Headache Center, the Norwegian Institute of Public Health and WHO.

Rehaler - About us

Scientific information

In the articles below you can find more about the technology behind Rehaler. If you have trouble finding them, we can help.

Clinical studies of CO2 in the treatment of migraine and headache

Titel
Journal
Year
Effects of carbon dioxide-oxygen mixtures given during preheadache pha...
Anaesthesia
1974
Trial treatment of migraine attack by rebreathing of expired air
Presse médicale
1984
Non-inhaled, intranasal carbon dioxide for the abortive treatment of m...
Annals of Neurology
2005
Abortive treatment of migraine headache with non-inhaled, intranasal c...
Headache
2005b

CO2's attenuation of pain and nervous system susceptibility

Titel
Journal
Year
Adenosine and ATP link PCO₂ to cortical excitability via pH
Neuron
2005
Non-inhaled administration of 100% carbon dioxide represses capsaicin ...
Cephalalgia
2009
Effect of carbon dioxide on calcitonin gene-related peptide secretion ...
Headache
2007
pH modulation of neuronal excitability and central nervous system func...
pH and Brain Function
1998
Trigeminal antihyperalgesic effect of intranasal carbon dioxide
Life Sciences
2010
Seizure termination by acidosis depends on ASIC1a
Nature neuroscience
2008
Carbonic anhydrases and brain pH in the control of neuronal excitabili...
Subcell Biochem
2014
Possible roles of vertebrate neuroglia in potassium dynamics, spreadin...
The Journal of experimental biology
1981
Mild acidosis delays hypoxic spreading depression and improves neurona...
Journal of Neuroscience
1994
Modulation of spreading depression by changes in extracellular pH
Journal of neurophysiology
2000

Download our press kit

Pressekittet indeholder yderligere information om BalancAir, Rehaler, fakta omkring migræne, links, billeder, logoer og andet

Contact us

We use cookies to deliver content, for statistics and to improve your experience on the site. By using rehaler.com you accept the terms for the use of cookies.

Login to your Rehaler account